Journal of Virology · 2015 · 31 citations · 8 references
Life SciencesImmunologyInfectious DiseasesMucosal ImmunologyVaccine ImmunologyVaccinologyAntiviral ImmunityCellular Immunity In InfectionMucosal ImmunityMucosal ImmunizationMucosal VaccinesViral VaccinesAnti-viral ImmunityCd8 Positive T CellsEnhanced ProtectionImmunodominant AntigensLinear EpitopesMucosal Antiviral ImmunityPeptide EpitopesVaccine-induced Antiviral Immunity
Here, we show that a CD40L-adjuvanted DNA/modified vaccinia virus Ankara (MVA) simian immunodeficiency virus (SIV) vaccine enhances protection against a pathogenic neutralization-resistant mucosal SIV infection, improves long-term viral control, and prevents AIDS. Analyses of serum IgG antibodies to linear peptides of SIV Env revealed a strong response to V2, with targeting of fewer epitopes in the immunodominant region of gp41 (gp41-ID) and the V1 region as a correlate for enhanced protection. Greater expansion of antiviral CD8 T cells in the gut correlated with long-term viral control.
8
Jung Joo Hong, Praveen K. Amancha, Kenneth A. Rogers et al. · The Journal of Immunology · 2012 · 150 citations · Full text
Koen K. A. Van Rompay, Jennifer Greenier, Kelly Stefano Cole et al. · Journal of Virology · 2002 · 93 citations · Full text
Medicine, Immunology, Pediatrics +17
Suefen Kwa, Lilin Lai, Sailaja Gangadhara et al. · Journal of Virology · 2014 · 62 citations · Full text